Literature DB >> 8200622

p53 immunostaining suggests that uterine carcinosarcomas are monoclonal.

F Mayall1, K Rutty, F Campbell, H Goddard.   

Abstract

The histogenesis of carcinosarcomas has intrigued pathologists for a long time and remains unresolved. Two main theories have been put forward, one suggesting that they are monoclonal, another suggesting that they are biclonal. Our study examined p53 immunostaining in 17 uterine carcinosarcomas (mixed Müllerian tumours) and found positivity in five (30%). There was no disparity in immunostaining between the epithelial and the stromal components in any of the 17 tumours. This concordance in every tumour would be very unlikely if carcinosarcomas are biclonal. However, it would be expected if carcinosarcomas are monoclonal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200622     DOI: 10.1111/j.1365-2559.1994.tb00512.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  10 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Histogenetic heterogeneity in carcinosarcoma of the esophagus: report of a case with immunohistochemical and molecular analyses.

Authors:  S Nakagawa; T Nishimaki; T Suzuki; N Yokoyama; S Kuwabara; K Hatakeyama
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

3.  Which is worse: uterine papillary serous carcinomas or carcinosarcomas?

Authors:  Taejong Song; Chel Hun Choi; Yoo-Young Lee; Tae-Joong Kim; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

Review 4.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

5.  Primary malignant mixed müllerian tumor of the peritoneum a case report with review of the literature.

Authors:  Fisnik Kurshumliu; Helle Rung-Hansen; Vibeke Ravn Skovlund; Lumturije Gashi-Luci; Thomas Horn
Journal:  World J Surg Oncol       Date:  2011-02-04       Impact factor: 2.754

6.  Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study.

Authors:  Alexander Schipf; Doris Mayr; Thomas Kirchner; Joachim Diebold
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

7.  A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.

Authors:  Elizabeth L Dickson; Rachel Isaksson Vogel; Paola A Gehrig; Stuart Pierce; Laura Havrilesky; Angeles Alvarez Secord; Joseph Dottino; Amanda N Fader; Stephanie Ricci; Melissa A Geller
Journal:  Gynecol Oncol       Date:  2015-09-06       Impact factor: 5.482

8.  Carcinosarcoma of monoclonal origin arising in a dermoid cyst of ovary: a case report.

Authors:  Daniela Cabibi; Anna Martorana; Francesco Cappello; Elisa Barresi; Claudio Di Gangi; Vito Rodolico
Journal:  BMC Cancer       Date:  2006-03-01       Impact factor: 4.430

9.  miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.

Authors:  Jill H Tseng; Maria Bisogna; Lien N Hoang; Narciso Olvera; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Anil K Sood; Douglas A Levine; Petar Jelinic
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

10.  Ovarian Carcinosarcoma with Retroperitoneal Para-Aortic Lymph Node Dissemination Followed by an Unusual Postoperative Complication: A Case Report with a Brief Literature Review.

Authors:  Stoyan Kostov; Yavor Kornovski; Yonka Ivanova; Deyan Dzhenkov; George Stoyanov; Stanislav Stoilov; Stanislav Slavchev; Ekaterina Trendafilova; Angel Yordanov
Journal:  Diagnostics (Basel)       Date:  2020-12-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.